Similar articles

• Mono--and polyvalent Pseudomonas aeruginosa vaccines. Preparation, control and administration.

  Meitert E, Meitert T, Sima F, Savulian C. Meitert E, et al. Arch Roum Pathol Exp Microbiol. 1982 Apr-Jun;41(2):105-14. Arch Roum Pathol Exp Microbiol. 1982. PMID: 6816188 Review. No abstract available.
• Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.

  Meitert E, Sima F, Savulian C, Petrovici M, Chersulick E, Costache G. Meitert E, et al. Arch Roum Pathol Exp Microbiol. 1989 Jul-Sep;48(3):237-51. Arch Roum Pathol Exp Microbiol. 1989. PMID: 2519634
• [Development of immunological preparations and their use for preventing and treating pyocyanic infection in burn patients].

  Kolker II, Stanislavskiĭ ES, Grishina IA, Panova IuM, Krokhina MA. Kolker II, et al. Probl Gematol Pereliv Krovi. 1981 Jan;26(1):29-33. Probl Gematol Pereliv Krovi. 1981. PMID: 6784114 Clinical Trial. Russian. No abstract available.
• Efficiency of Pseudomonas aeruginosa vaccines in the prevention and treatment of Pseudomonas infections in burned patients.

  Ionescu A, Meitert E, Vasiliu S, Meitert T, Sima F, Savulian C, Milicescu S. Ionescu A, et al. Arch Roum Pathol Exp Microbiol. 1981 Oct-Dec;40(4):323-32. Arch Roum Pathol Exp Microbiol. 1981. PMID: 6803737 No abstract available.
• Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa.

  Cachia PJ, Hodges RS. Cachia PJ, et al. Biopolymers. 2003;71(2):141-68. doi: 10.1002/bip.10395. Biopolymers. 2003. PMID: 12767116 Review.